Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company has shown just 20 months working with the last eight months reporting negative earnings. The company has a long gestation period to migrate to the main board as its post IPO equity remains small. The issue expenses indicate a fully structured IPO with pre-funding arrangements. It operates in a highly competitive and fragmented segment. Based on its financial data, the issue is exorbitantly priced. There is no harm in avoiding this issue. Read detail review...
Alkosign IPO Reviews, analysis and views by popular members. Read Alkosign Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP